Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FOXN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AQP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA5L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
U2SURP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXCT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPKAPK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPRIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF207 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP63 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on